Save your place

Sign in to WhoBought

Please try again later.

Invesco's Bioceres Crop Solutions Corp. (BIOX) position

Yes: as of Q1 2026, Invesco holds 126K shares of BIOX worth $109K (0.0% of the disclosed portfolio). Last quarter the position was increased by 268.8%. First disclosed Q4 2025.
View full portfolio →
Current value
$109K
Shares held
126K
% of portfolio
0.0%
Est. average buy price (i)
$1.32
Quarter-end price
$0.86

Estimated trade prices

Average price in quarters with purchases
$1.32

BIOX price vs Invesco's position

1Y 3Y 5Y MAX
Dates
$0.3$5$10$15$2020192020202120222023202420252026New position of 34K shares · Q4 2025. Average closing price $1.60 · Price range $1.27–$2.0334KsharespurchasedAdded 92K shares (268.8%) · Q1 2026. Average closing price $1.22 · Price range $0.84–$1.5392Ksharespurchased
Average closing price · filing quarter
$1.22
Price range · filing quarter
$0.84 – $1.53
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Added +92K +$112K +268.8% 126K May 12, 2026
Q4 2025 New +34K +$55K – 34K Feb 19, 2026
Data through Q1 2026 · filed May 12, 2026
2 grouped rows from 2 quarters

More Invesco positions

NVIDIA Corporation(NVDA)
$24.7B
3.8% of portfolio

Apple Inc.(AAPL)
$18.4B
2.8% of portfolio

Microsoft Corporation(MSFT)
$15.7B
2.4% of portfolio

Alphabet Inc.(GOOGL)
$12.9B
2.0% of portfolio

Amazon.com, Inc.(AMZN)
$11.8B
1.8% of portfolio

Broadcom Inc.(AVGO)
$10.3B
1.6% of portfolio

Common questions

Does Invesco own BIOX?

Yes. As of Q1 2026, Invesco disclosed 126K shares of BIOX, worth $109K. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Invesco buy BIOX?

Invesco first disclosed a BIOX position in Q4 2025; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Invesco sell BIOX?

The quarter-by-quarter table above shows each sale and reduction Invesco disclosed in BIOX. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of BIOX does Invesco own?

Invesco disclosed 126K shares of BIOX as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Invesco pay for BIOX?

Invesco's estimated average buy price for BIOX is $1.32, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.